References

Glioma

10.1038/s41572-024-00516-y · 2024 · External reference

Glioblastoma and other primary brain malignancies in adults: a review

10.1001/jama.2023.0023 · 2023 · External reference

Strategies to improve drug delivery across the blood-brain barrier for glioblastoma

10.1007/s11910-024-01338-x · 2024 · External reference

How much is enough? Impact of efflux transporters on drug delivery leading to efficacy in the treatment of brain tumors

10.1007/s11095-023-03574-1 · 2023 · External reference

The blood-brain barrier: structure, regulation, and drug delivery

10.1038/s41392-023-01481-w · 2023 · External reference

Blood-tumor barrier in focus - investigation of glioblastoma-induced effects on the blood-brain barrier

10.1007/s11060-024-04760-w · 2024 · External reference

Device-assisted strategies for drug delivery across the blood-brain barrier to treat glioblastoma

10.1038/s43246-024-00721-y · 2025 · External reference

Advances in nanocarriers for targeted drug delivery and controlled drug release

2025 · External reference

The nanocarrier strategy for crossing the blood-brain barrier in glioma therapy

2025 · External reference

Evolution of blood-brain barrier in brain diseases and related systemic nanoscale brain-targeting drug delivery strategies

10.1016/j.apsb.2020.11.023 · 2021 · External reference

The impact of nanoparticle protein Corona on cytotoxicity, immunotoxicity and target drug delivery

10.2217/nnm.15.188 · 2016 · External reference

Principles of nanoparticle design for overcoming biological barriers to drug delivery

10.1038/nbt.3330 · 2015 · External reference

Precision drug delivery to the central nervous system using engineered nanoparticles

10.1038/s41578-024-00695-w · 2024 · External reference

Cell membrane-based nanoparticles: a new biomimetic platform for tumor diagnosis and treatment

10.1016/j.apsb.2017.11.009 · 2018 · External reference

Cell membrane camouflaged nanoparticle strategy and its application in brain disease: a review

10.1007/s40005-024-00680-z · 2024 · External reference

A modular approach to enhancing cell membrane-coated nanoparticle functionality using genetic engineering

10.1038/s41565-023-01533-w · 2024 · External reference

Mesenchymal stem cells as therapeutic vehicles for glioma

10.1038/s41417-024-00775-7 · 2024 · External reference

Biomimetic immortalized mesenchymal stem cell-based nanoparticles suppress orthotopic postsurgical glioma via CD73 targeting and chemotherapy

10.1016/j.jconrel.2025.114297 · 2025 · External reference

Artificial mesenchymal stem cell extracellular vesicles enhanced ischemic stroke treatment through targeted remodeling brain microvascular endothelial cells

10.1016/j.apsb.2025.06.009 · 2025 · External reference

Stem cell membrane-coated abiotic nanomaterials for biomedical applications

10.1016/j.jconrel.2022.09.012 · 2022 · External reference

Cell membrane biomimetic nanoplatforms: a new strategy for immune escape and precision targeted therapy

2025 · External reference

Recent advances in mesenchymal stem cell membrane-coated nanoparticles for enhanced drug delivery

10.1039/d0bm01164a · 2021 · External reference

Current progress of mesenchymal stem cell membrane-camouflaged nanoparticles for targeted therapy

10.1016/j.biopha.2023.114451 · 2023 · External reference

Stem cell membrane-camouflaged targeted delivery system in tumor

2022 · External reference

The piper at the gates of brain: a systematic review of surface modification strategies on lipid nanoparticles to overcome the blood-brain-barrier

10.1016/j.ijpharm.2024.124686 · 2024 · External reference

γ-Glutamyl transpeptidase-activable nanoprobe crosses the blood-brain barrier for immuno-sonodynamic therapy of glioma

2024 · External reference

Influence of surface ligand density and particle size on the penetration of the blood-brain barrier by porous silicon nanoparticles

10.3390/pharmaceutics15092271 · 2023 · External reference

Recent advances in mesoporous silica nanoparticle: synthesis, drug loading, release mechanisms, and diverse applications

10.3389/fnano.2025.1564188 · 2025 · External reference

The importance of particle shape in drug delivery

10.1038/s44222-026-00429-3 · 2026 · External reference

Non-spherical micro- and nanoparticles for drug delivery: progress over 15 years

10.1016/j.addr.2021.05.017 · 2021 · External reference

Non-spherical polymeric nanocarriers for therapeutics: the effect of shape on biological systems and drug delivery properties

10.3390/pharmaceutics15010032 · 2022 · External reference

Effect of micro- and nanoparticle shape on biological processes

10.1016/j.jconrel.2021.12.032 · 2022 · External reference

Nanoparticle shape is the game-changer for blood-brain barrier crossing and delivery through tunneling nanotubes among glioblastoma cells

10.1039/d4nr03174a · 2025 · External reference

Interactions at the cell membrane and pathways of internalization of nano-sized materials for nanomedicine

10.3762/bjnano.11.25 · 2020 · External reference

Exploration and insights into the cellular internalization and intracellular fate of amphiphilic polymeric nanocarriers

10.1016/j.apsb.2021.02.019 · 2021 · External reference

Size, shape, and flexibility influence nanoparticle transport across brain endothelium under flow

10.1002/btm2.10153 · 2020 · External reference

P-selectin-targeted nanocarriers induce active crossing of the blood-brain barrier via caveolin-1-dependent transcytosis

10.1038/s41563-023-01481-9 · 2023 · External reference

Trafficking through the blood-brain barrier is directed by core and outer surface components of layer-by-layer nanoparticles

10.1002/btm2.10636 · 2024 · External reference

Wrapping anisotropic microgel particles in lipid membranes: effects of particle shape and membrane rigidity

2023 · External reference

Engineered biomimetic cell membrane-coated polymeric nanostructures for cancer therapy

2025 · External reference

Targeting drugs to tumours using cell membrane-coated nanoparticles

10.1038/s41571-022-00699-x · 2023 · External reference

Mesoporous silica nanoparticles: a synthesis guide and research progress in the biomedical field

2024 · External reference

Multifunctional mesoporous silica nanoparticles for biomedical applications

10.1038/s41392-023-01654-7 · 2023 · External reference

Spherical and rod shaped mesoporous silica nanoparticles for cancer-targeted and photosensitizer delivery in photodynamic therapy

10.1039/d1tb02299g · 2022 · External reference

Permeability studies on in vitro blood-brain barrier models: physiology, pathology, and pharmacology

10.1007/s10571-004-1377-8 · 2005 · External reference

Spheroid-based drug screen: considerations and practical approach

10.1038/nprot.2008.226 · 2009 · External reference

rWTC-MBTA vaccine induces potent adaptive immune responses against glioblastomas via dynamic activation of dendritic cells

10.4028/b-wjqrp6 · 2024 · External reference

Ferrimagnetic nanochains-based mesenchymal stem cell engineering for highly efficient post-stroke recovery

2019 · External reference

Nanoparticle geometry and surface orientation influence mode of cellular uptake

10.1021/nn304439f · 2013 · External reference

Topoisomerase II poisons inhibit vertebrate DNA replication through distinct mechanisms

10.15252/embj.2022110632 · 2022 · External reference

Ki67 is a graded rather than a binary marker of proliferation versus quiescence

10.1016/j.celrep.2018.06.110 · 2018 · External reference